ArticleParasitology research2013
Bioefficacy of plant-mediated gold nanoparticles and Anthocepholus cadamba on filarial vector, Culex quinquefasciatus (Insecta: Diptera: Culicidae).
Article in Parasitology research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 37 citations in OpenAlex.
- Review
- Predators as Control Agents of Mosquito Larvae in Micro-Reservoirs (Review).Inland water biology · 2022Article
- Plant-mediated biosynthesis of nanoparticles as an emerging tool against mosquitoes of medical and veterinary importance: a review.Parasitology research · 2016Review
- Synthesis of silver and gold nanoparticles using Jasminum nervosum leaf extract and its larvicidal activity against filarial and arboviral vector Culex quinquefasciatus Say (Diptera: Culicidae).Environmental science and pollution research international · 2015Article
- Therapeutic efficacy of poly (lactic-co-glycolic acid) nanoparticles encapsulated ivermectin (nano-ivermectin) against brugian filariasis in experimental rodent model.Parasitology research · 2014Article
- Cadamba: A miraculous tree having enormous pharmacological implications.Pharmacognosy reviewsReview
- Eco-friendly approaches of zinc oxide and silver nitrate nanoparticles along with plant extracts againstScience progressArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mosquito-borne diseases in India, e.g., malaria, dengue, chikungunya, filariasis, and Japanese encephalitis cause thousands of deaths per year. Mosquito control is to enhance the health and quality of life of county residents and visitors through the reduction of mosquito populations. Mosquito control is of serious concern in developing countries like India due to the lack of general awareness, development of resistance, and socioeconomic reasons. Noble metal nanoparticles have been used because of their unique optical properties; especially gold and silver have a broad absorption band in the visible region of electromagnetic spectrum. Synthesis of gold nanoparticles using Cymbopogan citratus is an ecofriendly approach for safer environment. C. citratus leaf broth was a good reducing agent that converted chloroauric acid (HAuCl(4)) to metal gold and further heating converted it into nanoparticles. Characterization using UV spectrophotometer, X-ray diffraction, Fourier transform infrared spectroscopy, particle size analyzer, and transmission electron microscopy confirmed that the particles are gold nanoparticles ranging between 10 and 110 nm with an average particles size of 20 nm. Further biosynthesized gold nanoparticles and Anthocephalus cadamba were experimented for the larvicidal effect on the filarial vector, Culex quinquefasciatus. Results showed that the gold nanoparticles are much toxic than the plant extract. Observed lethal concentrations (LC(50) and LC(90)) were 1.08 and 2.76 ppm for gold nanoparticles and 21.82 and 79.52 ppm for the third instar of C. quinquefasciatus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.